Up next

Autoplay

New breast cancer drug study results are promising.

1 Views • 08/26/25
Share
Side Effects
Side Effects
Subscribers
0

Researchers are encouraged by the early results for patients using Z-endoxifen. The potent derivative of the drug tamoxifen was given to women with estrogen receptor positive metastatic breast cancer, the most common form of breast cancer in women whose disease has spread. The phase I study demonstrated endoxifen shows promise for patients whose cancer had continued to progress with standard estrogen therapies, including tamoxifen.

Show more
0 Comments sort Sort By

Up next

Autoplay